113 related articles for article (PubMed ID: 9563491)
1. Loss or altered subcellular localization of p27 in Barrett's associated adenocarcinoma.
Singh SP; Lipman J; Goldman H; Ellis FH; Aizenman L; Cangi MG; Signoretti S; Chiaur DS; Pagano M; Loda M
Cancer Res; 1998 Apr; 58(8):1730-5. PubMed ID: 9563491
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases.
Thomas GV; Szigeti K; Murphy M; Draetta G; Pagano M; Loda M
Am J Pathol; 1998 Sep; 153(3):681-7. PubMed ID: 9736017
[TBL] [Abstract][Full Text] [Related]
3. Expression of p27(kip) and other cell cycle regulators in malignant peripheral nerve sheath tumors and neurofibromas: the emerging role of p27(kip) in malignant transformation of neurofibromas.
Kourea HP; Cordon-Cardo C; Dudas M; Leung D; Woodruff JM
Am J Pathol; 1999 Dec; 155(6):1885-91. PubMed ID: 10595919
[TBL] [Abstract][Full Text] [Related]
4. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers.
Lloyd RV; Erickson LA; Jin L; Kulig E; Qian X; Cheville JC; Scheithauer BW
Am J Pathol; 1999 Feb; 154(2):313-23. PubMed ID: 10027389
[TBL] [Abstract][Full Text] [Related]
5. p27 expression in inflammatory bowel disease-associated neoplasia. Further evidence of a unique molecular pathogenesis.
Walsh S; Murphy M; Silverman M; Odze R; Antonioli D; Goldman H; Loda M
Am J Pathol; 1999 Nov; 155(5):1511-8. PubMed ID: 10550307
[TBL] [Abstract][Full Text] [Related]
6. Translating Molecular Biology Discoveries to Develop Targeted Cancer Interception in Barrett's Esophagus.
Samaddar S; Buckles D; Saha S; Zhang Q; Bansal A
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511077
[TBL] [Abstract][Full Text] [Related]
7. Targeting the COP9 signalosome for cancer therapy.
Du W; Zhang R; Muhammad B; Pei D
Cancer Biol Med; 2022 Mar; 19(5):573-90. PubMed ID: 35315259
[TBL] [Abstract][Full Text] [Related]
8. Loss of p27Kip1 leads to expansion of CD4+ effector memory T cells and accelerates colitis-associated colon cancer in mice with a T cell lineage restricted deletion of Smad4.
Choi SH; Barker EC; Gerber KJ; Letterio JJ; Kim BG
Oncoimmunology; 2020 Dec; 9(1):1847832. PubMed ID: 33329939
[TBL] [Abstract][Full Text] [Related]
9. Expression of p27 and p16 and their clinical significance in gastric cancer.
Kumari S; Kumar P; Kumar M; Singh S; Narayan G
Clin Transl Oncol; 2021 Apr; 23(4):856-865. PubMed ID: 32880047
[TBL] [Abstract][Full Text] [Related]
10. Mislocalized cytoplasmic p27 activates PAK1-mediated metastasis and is a prognostic factor in osteosarcoma.
Chen X; Cates JMM; Du YC; Jain A; Jung SY; Li XN; Hicks JM; Man TK
Mol Oncol; 2020 Apr; 14(4):846-864. PubMed ID: 31872963
[TBL] [Abstract][Full Text] [Related]
11. From genetics to signaling pathways: molecular pathogenesis of esophageal adenocarcinoma.
Caspa Gokulan R; Garcia-Buitrago MT; Zaika AI
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):37-48. PubMed ID: 31152823
[TBL] [Abstract][Full Text] [Related]
12. The Emerging Role of p27 in Development of Diseases.
Yang Q; Al-Hendy A
Cancer Stud Mol Med; 2018 Nov; 4(1):e1-e3. PubMed ID: 30474063
[No Abstract] [Full Text] [Related]
13. Expression of p27 and c-Myc by immunohistochemistry in breast ductal cancers in African American women.
Khan F; Ricks-Santi LJ; Zafar R; Kanaan Y; Naab T
Ann Diagn Pathol; 2018 Jun; 34():170-174. PubMed ID: 29715580
[TBL] [Abstract][Full Text] [Related]
14. CacyBP/SIP promotes the proliferation of colon cancer cells.
Zhai H; Shi Y; Chen X; Wang J; Lu Y; Zhang F; Liu Z; Lei T; Fan D
PLoS One; 2017; 12(2):e0169959. PubMed ID: 28196083
[TBL] [Abstract][Full Text] [Related]
15. p27 Is a Candidate Prognostic Biomarker and Metastatic Promoter in Osteosarcoma.
Li Y; Nakka M; Kelly AJ; Lau CC; Krailo M; Barkauskas DA; Hicks JM; Man TK
Cancer Res; 2016 Jul; 76(13):4002-11. PubMed ID: 27197201
[TBL] [Abstract][Full Text] [Related]
16. Emerging therapeutic targets in esophageal adenocarcinoma.
Gaur P; Hunt CR; Pandita TK
Oncotarget; 2016 Jul; 7(30):48644-48655. PubMed ID: 27102294
[TBL] [Abstract][Full Text] [Related]
17. The non-canonical functions of p27(Kip1) in normal and tumor biology.
Sharma SS; Pledger WJ
Cell Cycle; 2016 May; 15(9):1189-201. PubMed ID: 27082696
[TBL] [Abstract][Full Text] [Related]
18. ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab.
Kurozumi S; Inoue K; Takei H; Matsumoto H; Kurosumi M; Horiguchi J; Takeyoshi I; Oyama T
BMC Cancer; 2015 Sep; 15():622. PubMed ID: 26345461
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.
Mikhail S; Albanese C; Pishvaian MJ
Am J Pathol; 2015 May; 185(5):1185-97. PubMed ID: 25747534
[TBL] [Abstract][Full Text] [Related]
20. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survival.
Niu ZS; Niu XJ; Wang M
World J Hepatol; 2015 Jan; 7(1):7-27. PubMed ID: 25624992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
